Find your path to Yara
1,519 people in our graph share verified history with Yara — schools, employers, funds. One of them is your warm intro.
Dominic JacquessonunlockedYara: together at University of Oxford
×11Yara: together at University of Oxford
About
Investor at Crane based in London with experience from MassMutual Ventures Europe & APAC, where she led healthtech and biotech investments. She is a trained biomedical scientist holding a DPhil from Oxford.
Experience
- Crane Venture PartnersInvestorcurrent2025 — presentLondon, England, United Kingdom
- BioInnovation InstituteVenture House Advisory Boardcurrent2024 — present
- nyra healthBoard Membercurrent2023 — present
- XUNDBoard Membercurrent2025 — present
- DePolyBoard Observercurrent2025 — present
- DayeBoard Observercurrent2025 — present
- HelloBetterBoard Observercurrent2023 — present
- Science Entrepreneur ClubTechBio Chapter Champion - BioCapital Networkcurrent2024 — presentLondon, England, United Kingdom
- The Saudi British SocietyMembercurrent2024 — presentLondon, England, United Kingdom
- TurbineBoard Member2023 — 2025
- MassMutual VenturesInvestor, Healthtech & Biotech Lead2022 — 2025Greater London, England, United Kingdom
- OrganOxAngel Investor2021 — 2025
- Royal Embassy of Saudi Arabia Cultural BureauMentor2024London, England, United Kingdom
- Oxford Investment ConsultantsInvestment Analyst2020 — 2022London, Greater London, United Kingdom
- Momentum Bioscience LtdBoard Observer2020 — 2022
- Worcester College, OxfordCoordinator of the Franks Society Talks, Worcester College, University of Oxford2016 — 2018Greater Oxford Area
Skills & more
Languages Arabic · English
From Yara's professional profile.
Colleagues at Crane Venture Partners
Aga Paliwoda
Executive Assistant to Co-Founders at Crane Venture Partners
Aleksandra Totoń
Fund Controller at Crane Venture Partners
Alisha Fernandes
Executive Assistant, India Team at Crane Venture Partners
Anandamoy Roychowdhary
Managing Director, India & APAC at Crane Venture Partners
Andy Leaver
General Partner at Crane Venture Partners
Anna Cachadiña Abelló
Investor at Crane Venture Partners
Ashwwani Verma
Director Legal at Crane Venture Partners
Ayala Ples
Head of Platform at Crane Venture Partners
Frequently asked questions
- Who is Yara Alenazi?
- Investor at Crane based in London with experience from MassMutual Ventures Europe & APAC, where she led healthtech and biotech investments. She is a trained biomedical scientist holding a DPhil from Oxford.
- Where does Yara Alenazi work?
- Yara Alenazi is Investor at Crane Venture Partners.
- Where did Yara Alenazi go to school?
- Yara Alenazi studied at University of Oxford (Doctor of Philosophy - DPhil, Cardiovascular Medicine); University of Portsmouth (Master of Science - MSc, Biomedicine); University of Portsmouth (Bachelor of Science - BSc, Biomedical Sciences).
Same school
Also attended University of Oxford1,544
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index Ventures
+ 1,538 more
Also attended University of Portsmouth29
Katie DhiravanijakulaStrategic Operations Manager, Thailand at Sora VenturesJoshua WarrenHead of HR at GP BullhoundMark LaneGlobal Head of Corporate Communications at Fortress Investment GroupDavid RolfeInvestment Partner at NVM Private Equity LLPLuke HortonPartner and COO at Brenteca InvestmentsLarry LiuManaging Partner, Celtic House Asia Partners at Celtic House Venture Partners
+ 23 more
Shared employers
Also worked at XUND2
Also worked at Daye2
Also worked at Science Entrepreneur Club5
Also worked at Turbine6
Radhika AnanthHead of India & Investment Director at Hitachi VenturesJonathan HayPartner at Delin VenturesAlex GwytherInvestment Director at Mercia VenturesAnvesh RamineniVenture Partner at Endiya PartnersGabriele PapievyteAssociate at Inovia CapitalKlaus HoeflichCo-founder & former Chief Scientific Officer at Nested Therapeutics
